Tag: Quest Diagnostics
Report examines marijuana’s impact in Colorado and Washington
A new report from Smart Approaches to Marijuana (SAM) analyzes marijuana use and its consequences in the states where it is legal.
National Impaired Driving Prevention Month
President Obama proclaimed December 2014 as National Impaired Driving Prevention Month.
CNN reports on synthetic drugs
Media reports tragic accounts of taking synthetic drugs. Quest Diagnostics monitors these ever-changing substances to add to our drug test panels.
Hair testing and the Drug Testing Index
Compared to other drug test specimen types like urine and oral fluid, hair testing is often preferred for evaluating long-term patterns of drug use.
Reducing risk with workplace drug testing
A new infographic helps to highlight why drug testing is important for employers to remain vigilant as they work to keep their workplaces drug free.
New Oral-Eze packaging
Quest Diagnostics revealed new packaging for the Oral-Eze oral fluid collection system for workplace drug testing.
Detection of recent marijuana use continues to increase significantly in oral fluid testing
Data from the Quest Diagnostics Drug Testing Index shows that the detection of marijuana in oral fluid has increased for the second consecutive year.
Drug test collections video
Our most recent video highlights our different drug test collection services and the benefits of each.
Oxycodones positivity declines for the second consecutive year
The latest data from the Quest Diagnostics Drug Testing Index reports that the positivity rate for prescription opiates declined 8.3% in 2013.
Dangers of synthetic cannabinoids
Synthetic cannabinoids change frequently and Quest works to stay current with drug-use patterns by adding compounds to our drug test panels.
